I AM BIO

Hydroxychloroquine & the Shorting of Science


Listen Later

Patients with autoimmune diseases like lupus and rheumatoid arthritis have been forced to ration or skip doses of hydroxychloroquine during the pandemic due to shortages caused by off-label prescribing. Yet despite multiple FDA clinical studies that concluded the drug offers no clinical benefit against covid and may increase dangerous side effects; President Trump continues to use the bully pulpit to suggest otherwise. It's not like autoimmune patients — at greater risk of serious COVID disease, stress-induced flare-ups and vaccine complications — didn’t have enough to worry about already.
...more
View all episodesView all episodes
Download on the App Store

I AM BIOBy Biotechnology Innovation Organization

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

83 ratings


More shows like I AM BIO

View all
Nature Podcast by Springer Nature Limited

Nature Podcast

763 Listeners

Science Magazine Podcast by Science Magazine

Science Magazine Podcast

808 Listeners

More or Less: Behind the Stats by BBC Radio 4

More or Less: Behind the Stats

902 Listeners

This Week in Virology by Vincent Racaniello

This Week in Virology

2,048 Listeners

BioTech Nation ... with Dr. Moira Gunn by Moira Gunn

BioTech Nation ... with Dr. Moira Gunn

28 Listeners

Two Scientists Walk Into a Bar by Genentech

Two Scientists Walk Into a Bar

309 Listeners

DNA Today: A Genetics Podcast by Kira Dineen

DNA Today: A Genetics Podcast

158 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

117 Listeners

The Readout Loud by STAT

The Readout Loud

317 Listeners

BioBoss by John Simboli

BioBoss

7 Listeners

This Week in Neuroscience by Vincent Racaniello

This Week in Neuroscience

88 Listeners

Business Of Biotech by Matt Pillar

Business Of Biotech

84 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

141 Listeners

Taskmaster The Podcast by Avalon

Taskmaster The Podcast

631 Listeners

Conversations in Drug Development by Boyds

Conversations in Drug Development

3 Listeners